AI drug discovery
The latest news about AI drug discovery: headlines, AI summaries and the full story from every source.
- Isomorphic Labs, Spinout from Google DeepMind, Considering Funding Round with Valuation Between $40B and $50B
- Twist Bioscience Expands AI Drug Discovery Exposure Through Partnership with Lilly TuneLab
- Nvidia-backed AI drugmaker Iambic Therapeutics files for U.S. IPO
- AbbVie partners with Iambic Therapeutics on multi-year AI drug discovery collaboration
- Owkin partners with Boehringer Ingelheim for AI-driven drug discovery
- Nvidia GPUs Are Essential for AI Drug Discovery but Not a Determining Factor in Market Leadership
- Vivodyne Aims to Address Data Gaps in AI Drug Discovery with Human Tissue Models
- Twist Bioscience Reports Strong Q3 Growth, Raises Full-Year Revenue Guidance
- Insilico and SK Biopharmaceuticals Partner in $2.5B AI Drug Discovery Agreement
- Morgan Stanley Raises Price Target on Recursion Pharmaceuticals (RXRX)
- Evogene Reports Stronger-Than-Expected Earnings but Revenue Misses Estimates
- BullFrog AI Shares Strategic Progress and Outlook with Shareholders